Viagra maker Pfizer and Botox maker Allergan agree to merge in a roughly $160 billion deal, few days after Treasury tightened the rules on tax inversion.
Viagra maker Pfizer and Botox maker Allergan agree to merge in a roughly $160 billion deal, few days after Treasury tightened the rules on tax inversion.